Riskpilot← Back to searchSign inGet full accessOPTERA AS
ASActiveOrg 913600975Valkendorfsgaten 5, 5012 BergenMedical specialists activities · NACE 8622Est. 20145 employees
Revenue 2024
NOK 15,4M
-8% vs 2023
EBITDA margin
9.0%
+18% vs 2023
Equity ratio
30.4%
Financial strength
Net profit 2024
NOK 800K
+21% vs 2023
| Revenue | NOK 15,4M | -8% |
| EBITDA | NOK 1,4M | +18% |
| Net profit | NOK 800K | +21% |
| Total assets | NOK 2,9M | -11% |
| Equity | NOK 880K | +2% |
| Employees | 5 | — |
Legal name
OPTERA AS
Org number
913600975
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
12. juni 2014
Share capital
NOK 640 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Selskapets formål er å drive kirurgisk øyenlegetjeneste og annen forretningsdrift som står i sammenheng med dette, herunder deltakelse i selskap med samme formål.
Address
Valkendorfsgaten 5, 5012 Bergen
Phone
+4755210500
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 292 | 16 694 | 15 065 | 16 792 | 15 385 |
| Staff expenses | −5 326 | −5 653 | −5 299 | −6 650 | −3 439 |
| EBITDA | 1 463 | 2 224 | 1 184 | 1 173 | 1 384 |
| Depreciation & amort. | −321 | −310 | −296 | −325 | −352 |
| EBIT | 1 142 | 1 913 | 888 | 848 | 1 032 |
| Net financials | −0 | −0 | −6 | −1 | 4 |
| Profit before tax | 1 142 | 1 913 | 882 | 847 | 1 035 |
| Tax | 251 | 421 | 194 | 187 | 236 |
| Net profit | 891 | 1 492 | 688 | 660 | 800 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 303 | 3 835 | 3 192 | 3 233 | 2 892 |
| Equity | 826 | 914 | 902 | 860 | 880 |
| Long-term debt | 21 | 24 | 25 | 6 | 0 |
| Short-term debt | 2 457 | 2 897 | 2 264 | 2 367 | 2 012 |
| Total debt | 2 478 | 2 921 | 2 290 | 2 373 | 2 012 |
EBITDA margin
9.0%
This company
15.8%
Market median
-43% vs market
20202024
Equity ratio
30.4%
This company
38.2%
Market median
+20% vs market
20202024
Return on equity
90.9%
This company
18.4%
Market median
+394% vs market
20202024
Net profit margin
5.2%
This company
8.1%
Market median
-36% vs market
20202024
Asset turnover
5.32×
This company
1.12×
Market median
+375% vs market
20202024
Debt / equity
2.29×
This company
0.62×
Market median
-269% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KK Chief Executive Officer | Chief Executive Officer | 2014 |
SO Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2016 | |
| Chairman | 2026 | |
| Chairman | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Øyelege Solveig Otteren Ulvik As
OPTERA AS Board members of OPTERA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristen Kurt Realfsen | Chief Executive Officer | 0 companies |
| Solveig Otteren Ulvik | Chief Executive Officer | 0 companies |
| Vibeke Huun Birkeland | Board of Directors | 0 companies |
| Pål Tørvik-Pedersen | Chairman | 0 companies |
| Christian Haakon Bjune | Chairman | 0 companies |